Max Planck's Matthias Mann Discusses Technology Development and Clinical Proteomics
February 12, 2009
Max Planck's Matthias Mann Discusses Technology Development and Clinical Proteomics
By Tony Fong
In the first part of a two-part interview, Mann discusses the state of technology in proteomics and what still needs to get done for proteomics to cross to the clinical side.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.